Frontlight ResearchEarly access
Trial site
UCLA University of California Los Angeles
- 4running trials
- 4closed trials
The trials here
What the 8 trials at this site are about, from their registry records.
- Conditions
- IgA nephropathy2 trials
- Psoriasis2 trials
- Bladder cancer1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Lung cancer1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 35 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Completed4 trials
- Active, not recruiting3 trials
- Recruiting1 trial
- Lead sponsor
- Takeda3 trials
- Genentech, Inc.1 trial
- Hoffmann-La Roche1 trial
- Hookipa Biotech GmbH1 trial
- Jazz Pharmaceuticals1 trial
- and 1 more
Running trials
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Active, not recruiting
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
Active, not recruiting
Active, not recruiting
International Spontaneous Coronary Artery Dissection (SCAD) "iSCAD" Registry
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- IgA nephropathy1 recruiting
Closed trials
Completed
Completed
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026